NNovo Nordisk Read More Lexicon Q1 revenue hits $21.1M, cash rises to $199.7M2026-05-07 Lexicon Pharmaceuticals (Nasdaq: LXRX) reported Q1 2026 results and pipeline updates on May…
NNovo Nordisk Read More Lexicon earns $10M as Novo starts LX9851 Phase 12026-03-25 Lexicon Pharmaceuticals (Nasdaq: LXRX) and Novo Nordisk announced initiation of a Phase 1…